Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

NCT05164016 · clinicaltrials.gov ↗

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Hematopoietic System--Cancer
Transplant-Related Cancer
Solid Tumor Malignancy
Hematologic Malignancy
Solid Organ Transplant
Hematopoietic Cell Transplant
Cellular Therapy

Sponsor

St. Jude Children's Research Hospital